Leah Rosenbaum, Forbes Staff

Author's posts

Locked Rooms, Tracking Devices And Bulletproof Glass: How Pharmacies Are Securing Covid-19 Vaccines

As Covid-19 vaccines from Pfizer and Moderna are distributed across the country, hospitals and pharmacies work to keep doses locked away, using lessons learned from managing prescriptions during the opioid epidemic.

Forbes Biotech & Pharma Awards 2020: Here Comes The Vaccine Bonanza

Faced with a once-in-a-century pandemic, biotech and pharma companies stepped up to the plate in a major way. Here are the best products, most intriguing people and most exciting trends of 2020.

The Feds’ Risky Billion Dollar Bet On Moderna Pays Off As FDA Authorizes Its Covid-19 Vaccine

In early 2020, the federal government took a gamble on a plucky startup that had never had an approved medication could produce a Covid-19 vaccine. On Friday, it got paid off as Moderna’s vaccine got a regulatory signoff and will start being distribute…

Vaccine Advisory Committee Votes Yes On Moderna’s Covid-19 Vaccine, FDA Authorization Could Come Soon

The second Emergency Use Authorization for a Covid-19 vaccine could be days – or even hours – away.

Pfizer Says It Has Millions Of Vaccine Doses ‘Sitting In Our Warehouse’ But Hasn’t Been Told Where To Send Them

The company says that it has extra doses of the Covid-19 vaccine, but is waiting on instructions from the U.S. government before it can deliver them to hospitals.

U.S. Healthcare Worker Reportedly Had Severe Allergic Reaction To Pfizer Covid-19 Vaccine, But Experts Say Vaccine Is Still Safe

This is the third known allergic reaction to the Pfizer-BioNTech Covid-19 vaccine

FDA Authorizes Pfizer And BioNTech’s Covid-19 Vaccine For Use In The United States

On Friday, the U. S. Food and Drug Administration granted Emergency Use Authorization to Pfizer and BioNTech’s Covid-19 vaccine, the first vaccine that will be available for public use in the U. S.

Vaccine Advisory Committee Endorses Pfizer Covid-19 Vaccine, Paves Way For FDA Authorization

The first Emergency Use Authorization for a Covid-19 vaccine could be hours or days away.

EXCLUSIVE: Billionaire Eric Lefkofsky’s Tempus Raises $200 Million To Bring Personalized Medicine To New Diseases

The Groupon cofounder’s precision medicine company, which uses AI-based diagnostics, has broadened its focus to infectious disease and cardiology in addition to cancer.

The U.S. Has Ordered Enough Of Pfizer’s Covid-19 Vaccine For 50 Million People—But That’s All

The U.S. government had the option to buy 500 million additional doses of the Pfizer-BioNTech Covid-19 vaccine, but sources say that so far there are no plans to purchase additional doses.